Ramada Plaza Thraki Hotel,
For one more consecutive year, IASIS PHARMA was present to the 39th Panhellenic Gastroenterology Conference, organized by the Hellenic Society of Gastroenterology (E.G.E) at Ramada Plaza Thraki Hotel, Alexandroupoli, 10-13 October 2019.
The conference’s initiators achieved for the conference to point out the most recent scientific work of the Greek Gastroenterologists, thus updating and informing all attending experts who focus in the fields of gastroenterology and hepatology.
IASIS PHARMA proved its active participation with Mastihatherapy® caps, the unique traditional herbal medicinal product, containing 350mg of pure Chios Mastic (Pistacia lentiscus), recommended for the treatment of functional dyspepsia.
Medical experts showed a strong interest about this herbal medicinal product (E.M.A. 2015), that is known to humanity for over 2500 years. Having several historical reports, but also many scientific studies published in the recent times, such as the method of detection for the unique ingredients of original Chios Mastic, i.e. masticadienonic acid and iso-masticadienonic acid, the substances that are responsible for the anti-inflammatory properties of the original Chios Mastic.
IASIS PHARMA is the only pharmaceutical company that is supplied with pure Chios Mastic directly from Chios Mastic Growers Association (EMX), ensuring the quality and authenticity of Mastihatherapy® caps.
Mastihatherapy® caps are distributed only through pharmacies, in 30 and 90 capsules packages, by Pharma Q, a company of IASIS PHARMA group.
Worth mentioning is the fact that during the conference IASIS PHARMA also presented:
– its key role participation to the establishment of the unique Mastiha Research and Innovation Center (K.E.M), based in Kallimasia, Chios island.
– its new, state-of-the-art Production Facilities, Distribution Center and R&D Center, which are now completed and active in the region of Koropi, Athens.